
Teladoc Health, Inc.· TDOC
- Price
- $6.71
- Day
- +0.45%
- Mkt Cap
- $1.22B
- 52W Range
- $4.40 – $9.89
- Volume
- 5.21M
- Beta
- 2.10

Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.

NEW YORK--(BUSINESS WIRE)--Five months after guiding full-year 2026 consolidated revenue to a range of $2.47 billion to $2.59 billion, Teladoc Health (NYSE: TDOC) reduced that outlook to $2.36 billion to $2.45 billion, and shares fell nearly 30%. If you lost money holding Teladoc Health shares, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.On the February 25, 2026 fourth qua.
Read full article
Five months after guiding full-year 2026 consolidated revenue to a range of $2.47 billion to $2.59 billion, Teladoc Health (NYSE: TDOC) reduced that outlook to
Read full article
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read full article
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former president and chief operating officer of Verisk Analytics, a strategic data analytics and technology partner to the global insurance industry. He will serve on the board's Audit & Compensation committees.
Read full article
/PRNewswire/ -- A guidance reduction of $108 million at the bottom end following last quarter's slight uplift wiped nearly 30% of Teladoc Health (NYSE: TDOC)
Read full article
Teladoc Health projected its BetterHelp division to decline 7% to 0.5%. Following a quarter that featured a 12% annual decline, the Company is now telling investors to expect up to a 19% full-year revenue growth decline.
Read full article
Teladoc Health Inc. (NYSE:TDOC) shares are trading sharply lower during Thursday's premarket session as investors digest second-quarter results and a cautious outlook that undercut the beat on earnings.
Read full article
TDOC tops adjusted earnings estimates despite a revenue miss, as Integrated Care and international growth help cushion BetterHelp weakness and a lower 2026 outlook.
Read full article
Teladoc Health Inc (NYSE:TDOC) is plunging today after the virtual healthcare provider reported second-quarter revenue of $606.9 million, missing Wall Street's estimate of $615.4 million, and lowered its full-year revenue guidance.
Read full article
Teladoc shares fell more than 20% before the bell on Thursday, a day after the virtual healthcare provider trimmed its annual revenue forecast and flagged challenges at its mental health services unit BetterHelp.
Read full article
Teladoc Health NYSE: TDOC reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at BetterHelp prompted the company to reduce its full-year revenue outlook.
Read full article
Teladoc Health, Inc. (TDOC) Q2 2026 Earnings Call Transcript
Read full article